Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Ehleben

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Hepatology (Baltimore, Md.)|July 23, 2013
Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitorBrian L Pearlman, Carole Ehleben
Hepatology (Baltimore, Md.)|November 30, 2007
Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1-infected slow respondersBrian L Pearlman, Carole Ehleben, Sophia Saifee
Gastroenterology|January 6, 2015
The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosisBrian L Pearlman, Carole Ehleben, Michael Perrys
Journal of Surgical Education|December 9, 2008
Application submission date reflects applicant qualityGeorge M Fuhrman, Stephen Dada, Carole Ehleben
Journal of Surgical Education|July 16, 2010
Enhancing resident interest in a state surgical meetingGeorge M Fuhrman, Jana MacLeod, Carole Ehleben, et al.
Southern Medical Journal|December 2, 2024
Reducing Unnecessary Laboratory Testing: A Quality Improvement Initiative at Wellstar Spalding Medical CenterVishwanath Anil, Komal Harisinghani, Priyasi Monga, et al.
Journal of Trauma Nursing : the Official Journal of the Society of Trauma Nurses|April 10, 2026
Delirium Diagnosis Timing Among Trauma and Acute Care Surgery Ward PatientsMena Louis, Morgan A Krause, Laura Wolf, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Hepatology (Baltimore, Md.)|July 23, 2013
Hepatitis C genotype 1 virus with low viral load and rapid virologic response to peginterferon/ribavirin obviates a protease inhibitorBrian L Pearlman, Carole Ehleben
Hepatology (Baltimore, Md.)|November 30, 2007
Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1-infected slow respondersBrian L Pearlman, Carole Ehleben, Sophia Saifee
Gastroenterology|January 6, 2015
The combination of simeprevir and sofosbuvir is more effective than that of peginterferon, ribavirin, and sofosbuvir for patients with hepatitis C-related Child's class A cirrhosisBrian L Pearlman, Carole Ehleben, Michael Perrys
Journal of Surgical Education|December 9, 2008
Application submission date reflects applicant qualityGeorge M Fuhrman, Stephen Dada, Carole Ehleben
Journal of Surgical Education|July 16, 2010
Enhancing resident interest in a state surgical meetingGeorge M Fuhrman, Jana MacLeod, Carole Ehleben, et al.
Southern Medical Journal|December 2, 2024
Reducing Unnecessary Laboratory Testing: A Quality Improvement Initiative at Wellstar Spalding Medical CenterVishwanath Anil, Komal Harisinghani, Priyasi Monga, et al.
Journal of Trauma Nursing : the Official Journal of the Society of Trauma Nurses|April 10, 2026
Delirium Diagnosis Timing Among Trauma and Acute Care Surgery Ward PatientsMena Louis, Morgan A Krause, Laura Wolf, et al.
Pageof 1